Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | KIF11 | P52732 | 1/20 | 0.34 |
| ▸ | NOS1 | P29475 | 2/20 | 0.31 |
| ▸ | NOS2 | P35228 | 2/20 | 0.31 |
| ▸ | NOS3 | P29474 | 1/20 | 0.31 |
| ▸ | ARG1 | P05089 | 1/20 | 0.31 |
| ▸ | ARG2 | P78540 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4588024 | 0.86 | BHMT (0.33) | KIF11NOS1NOS2NOS3ARG1 | |
| SCHEMBL4589162 | 0.77 | ALDH1A1 (0.42) | ALDH1A1NOS1NOS2NOS3ARG1 | |
| SCHEMBL4587098 | 0.76 | ARG1 (0.33) | NOS1NOS2NOS3ARG1ARG2 | |
| SCHEMBL4586374 | 0.74 | TLR2 (0.32) | ARG1ARG2 | |
| SCHEMBL4618533 | 0.73 | PTGS1 (0.33) | ARG1ARG2 | |
| SCHEMBL4587301 | 0.73 | ARG1 (0.35) | NOS1NOS2NOS3ARG1ARG2 | |
| SCHEMBL4588714 | 0.72 | NOS2 (0.33) | ALDH1A1KIF11NOS1NOS2NOS3 | |
| SCHEMBL4587151 | 0.72 | NOS2 (0.33) | ALDH1A1KIF11NOS1NOS2NOS3 | |
| SCHEMBL4587000 | 0.70 | ARG1 (0.33) | ALDH1A1NOS1NOS2NOS3ARG1 | |
| SCHEMBL4588053 | 0.70 | GLO1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080287407-A1 | Nitric Oxide Releasing Pyruvate Compounds, Compositions and Methods of Use | NITROMED, INC. (US) | 2008-11-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080287407-A1 | Nitric Oxide Releasing Pyruvate Compounds, Compositions and Methods of Use | PC, PDK1, NOS3 | ALDH1A1 567/4885KIF11 3882/4885NOS1 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.